Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: A meta-analysis study

International Journal of Impotence Research

Volumn 26, Issue 5, 2014, Pages 161-166

  Yee, A ^a   Loh, H S ^b   Hisham Hashim, H M B ^a   Ng, C G ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Newcastle University Medicine Malaysia   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

AGE; FAMILY; HEALTH STATUS; HORMONE DETERMINATION; HUMAN; MAINTENANCE THERAPY; MALE; MALE SEXUAL DYSFUNCTION; MENTAL DISEASE; META ANALYSIS; METHADONE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL DYSFUNCTION; SUBSTANCE USE; TREATMENT DURATION; ADULT; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84927173772     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2014.18     Document Type: Review

References (43)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. JAMA 1999; 281: 537-544.
2. Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction case-control study. Br J Psychiatry 2003; 182: 50-56.
3. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000; 2: 189-195.
4. Grube M, Weigand-Tomiuk H. Sexual dysfunctions in a group of psychiatric inpatients]. Psychiatrische Praxis 2002; 29: 194.
5. Oksuz E, Malhan S. The prevalence of male sexual dysfunction and potential risk factors in Turkish men: a Web-based survey. Int J Impot Res 2005; 17: 539-545.
6. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009 CD002209.
7. Teusch L, Scherbaum N, Böhme H, Bender S. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment: results of an investigation by semi-structured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995; 28: 84-92.
8. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E. Function of the male sex organs in heroin and methadone users. N Engl J Med 1975; 292: 882-887.
9. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sexual Med 2008; 5: 684-692.
10. Patricia A, Cioe R, Peter D, Friedmann M, Stein MD. Erectile dysfunction in opioid users: lack of association with serum testosterone. J Addict Dis 2010; 29: 455-460.
11. Brown R, Balousek S, Mundt M, Michael Fleming MDM. Methadone maintenance and male sexual dysfunction. J Addict Dis 2005; 24: 91-106.
12. Chen W, Li X, Li X, Ling L, Xia Y, Chen J et al. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China. J Addict Med 2012; 6: 212-218.
13. Zhang Y, Wang P, Ma Z, Xu Z, Li Y. Sexual function of 612 male addicts treated by methadone. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011; 36: 739.
14. Nik Jaafar NR, Mislan N, Abdul Aziz S, Baharudin A, Ibrahim N, Midin M et al. Risk factors of erectile dysfunction in patients receiving methadone maintenance therapy. J Sexual Med 2013; 10: 2069-2076.
15. Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005; 90: 203-206.
16. Giacomuzzi S, Khreis A, Riemer Y, Garber K, Ertl M. Buprenorphine and methadone maintenance treatment-sexual behaviour and dysfunction prevalence. Lett Drug Design Discov 2009; 6: 13-.
17. Tatari F, Farnia V, Najafi F. Trazodone in methandone induced erectile dysfunction. Iran J Psychiatry 2010; 5: 164-166.
18. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-174.
19. Chekuri V, Gerber D, Brodie A, Krishnadas R. Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addict Behav 2012; 37: 124-126.
20. Hanbury R, Cohen M, Stimmel B. Adequacy of sexual performance in men maintained on methadone. Am J Drug Alcohol Abuse 1977; 4: 13-20.
21. Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug and Alcohol Depen 2008; 94: 12-18.
22. Baharudin A, Mislan N, Ibrahim N, Sidi H, Nik Jaafar NR. Depression in male patients on methadone maintenance therapy. Asia-Pacific Psychiatry 2013; 5: 67-73.
23. Spring WD, Willenbring ML, Maddux TL. Sexual dysfunction and psychological distress in methadone maintenance. Subst Use Misuse 1992; 27: 1325-1334.
24. Peugh J, Belenko S. Alcohol, drugs and sexual function: a review. J Psychoactive Drugs 2001; 33: 223-232.
25. Emanuele MA, Emanuele NV. Alcohol's effects on male reproduction. Alcohol Health Res World 1998; 22: 195-201.
26. Colameco S, Coren JS. Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009; 109: 20-25.
27. Peate I. The effects of smoking on the reproductive health of men. Br J Nurs 2005; 14: 362-367.
28. Fronczak CM, Kim ED, Barqawi AB. The insults of illicit drug use on male fertility. J Androl 2012; 33: 515-528.
29. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
30. McAnulty RD, Burnette MM. Sex and sexuality. Greenwood Publishing Group, 2006.
31. Lofwall MR, Stitzer ML, Bigelow GE, Strain EC. Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence. Addict Disord Treat 2005; 4: 49-64.
32. Yule M, Davison J, Brotto L. The international index of erectile function: a methodological critique and suggestions for improvement. J Sex Marital Ther 2011; 37: 255-269.
33. Rosen D, Smith ML, Reynolds III CF. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatric Psych 2008; 16: 488-497.
34. Mendelson JH, Mendelson JE, Patch VD. Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 1975; 192: 211-217.
35. Mendelson J, Meyer R, Ellingboe J, Mirin S, McDougle M. Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975; 195: 296-302.
36. Woody G, McLellan A, O'Brien C, Persky H, Stevens G, Arndt I et al. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monogr 1988; 81: 216-223.
37. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 2009; 32: 131-139.
38. Xia Y, Zhang D, Li X, Chen W, He Q, Jahn HJ et al. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China. Psychol Health Med 2013; 18: 321-329.
39. Daniell HW. Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict dis 2002; 21: 47-53.
40. Colameco S, Coren JS, Zimmerman DJ. Buprenorphine-induced symptomatic hypogonadism in men: case reports and discussion. J Addict Med 2008; 2: 147-150.
41. Dürsteler-MacFarland KM, Fischer DA, Mueller S, Schmid O, Moldovanyi A, Wiesbeck GA. Symptom complaints of patients prescribed either oral methadone or injectable heroin. J Subs Abuse Treat 2010; 38: 328-337.
42. Grönbladh L, Öhlund LS. Self-reported differences in side-effects for 110 heroin addicts during opioid addiction and during methadone treatment. Heroin Addict Relat Clin Probl 2011; 13: 5-12.
43. Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP et al. The medical status of methadone maintenance patients in treatment for 11-18 years. Drug Alcohol Depend 1993; 33: 235-245.